DRUG · COUNSELLING NOTES
Pembrolizumab (intravenous)
KEYTRUDA
Updated
New prescription
indication: _____. IV by HCP; report new cough, diarrhea, rash; warned on allergies; serious/common AEs: pneumonitis, colitis, thyroid problems, fatigue; non-pharm: activity pacing, sun protection
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV by HCP; report new cough, diarrhea, rash; warned on allergies; serious/common AEs: pneumonitis, colitis, thyroid problems, fatigue; non-pharm: activity pacing, sun protection